\
&
Contact us
\
&
Contact us
Published on | 2 years ago
ProgrammesThe amended version of the Widening participation and strengthening the European Research Area (WIDERA) work programme has been published on the European Commission Funding and Tenders Portal. The main changes for the Strengthening the ERA by reforming and enhancing the EU research and innovation system part of the WIDERA work programme concerns the introduction of a new call HORIZON-WIDERA-2024-ERA-02-01 with one postponed and two new call topics. Expected opening of the call: 15 May 2024 and deadline: 25 September 2024.
Other new actions added:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health EIT AI Continent Deployment: Best use of technologies
EIT Health’s Innovation Uptake Call focuses on mature digital, data-driven and AI-powered solutions and seeks to support the last steps towards commercialisation. Applicants must apply as a consortium of at least two independent legal entities from different countries. The consortium must include partners from at least two sides of the Knowl... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
